Panion & Bf Biotech Inc. (TPE:1760)
Taiwan · Delayed Price · Currency is TWD 64.10
+0.10 (0.16%)
At close: Mar 24, 2026
Panion & Bf Biotech Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 190.17 | 124.52 | 77.22 | 182.35 | 104.4 |
Depreciation & Amortization | 138.42 | 164.42 | 170.39 | 163.55 | 143.62 |
Loss (Gain) From Sale of Assets | 0.13 | 0.1 | 0.38 | -6.28 | 0.44 |
Loss (Gain) From Sale of Investments | -0.24 | -1.46 | -7.5 | 93.68 | -6.72 |
Loss (Gain) on Equity Investments | -2.65 | 8.44 | 14.02 | 8.18 | 12.17 |
Stock-Based Compensation | - | - | - | - | 11.72 |
Provision & Write-off of Bad Debts | 0.85 | -0.33 | -1.05 | 0.08 | 2.09 |
Other Operating Activities | -14.84 | -16.02 | -27.98 | 44.15 | 8.81 |
Change in Accounts Receivable | 1.08 | 4.72 | 1.31 | -9.7 | 23.61 |
Change in Inventory | -41.95 | 12.62 | 7.12 | -15.88 | 32.33 |
Change in Accounts Payable | 9.27 | 19.8 | 8.21 | -5.69 | -31.94 |
Change in Other Net Operating Assets | 29.34 | 34.37 | -64.69 | 65.4 | 69.98 |
Operating Cash Flow | 309.57 | 351.19 | 177.42 | 489.87 | 401.23 |
Operating Cash Flow Growth | -11.85% | 97.94% | -63.78% | 22.09% | - |
Capital Expenditures | -148.34 | -185.69 | -181.23 | -198.64 | -170.01 |
Sale of Property, Plant & Equipment | - | 0.11 | 0.01 | 24.72 | - |
Sale (Purchase) of Intangibles | -10 | - | - | - | - |
Investment in Securities | 27.87 | 13.19 | 15.05 | 15 | -43.01 |
Other Investing Activities | 1.29 | 13.62 | 10.9 | 14.46 | -2.03 |
Investing Cash Flow | -129.18 | -158.77 | -155.27 | -144.47 | -215.05 |
Short-Term Debt Issued | 920 | 1,205 | 1,305 | 1,705 | 1,931 |
Long-Term Debt Issued | 35 | 59.24 | 117.86 | 22.9 | 54.38 |
Total Debt Issued | 955 | 1,264 | 1,423 | 1,728 | 1,985 |
Short-Term Debt Repaid | -1,000 | -1,240 | -1,165 | -1,575 | -2,131 |
Long-Term Debt Repaid | -63.29 | -45.41 | -31.12 | -181.61 | -634.13 |
Total Debt Repaid | -1,063 | -1,285 | -1,196 | -1,757 | -2,765 |
Net Debt Issued (Repaid) | -108.29 | -21.17 | 226.74 | -28.71 | -779.75 |
Issuance of Common Stock | - | - | - | - | 628.43 |
Common Dividends Paid | -154.33 | -128.61 | -171.48 | -128.61 | -53.72 |
Other Financing Activities | -15.29 | -20.73 | -6.6 | -10.07 | -12.72 |
Financing Cash Flow | -277.9 | -170.51 | 48.67 | -167.39 | -217.76 |
Foreign Exchange Rate Adjustments | -0.54 | 1.84 | -0.44 | 7.14 | 0.58 |
Net Cash Flow | -98.06 | 23.75 | 70.37 | 185.15 | -31.01 |
Free Cash Flow | 161.23 | 165.49 | -3.81 | 291.23 | 231.22 |
Free Cash Flow Growth | -2.57% | - | - | 25.95% | - |
Free Cash Flow Margin | 7.81% | 8.15% | -0.20% | 12.14% | 12.16% |
Free Cash Flow Per Share | 1.87 | 1.93 | -0.04 | 3.39 | 2.92 |
Cash Interest Paid | 15.05 | 14.61 | 11.08 | 7.64 | 14.7 |
Cash Income Tax Paid | 128.76 | 122.64 | 119.05 | 109.11 | 76.91 |
Levered Free Cash Flow | 202.66 | 93.15 | 46.79 | 300.67 | 187.8 |
Unlevered Free Cash Flow | 211.63 | 102.54 | 53.89 | 305.41 | 196.97 |
Change in Working Capital | -2.27 | 71.51 | -48.06 | 4.17 | 124.7 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.